U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
– Advertisement –
Menu
Trump says Iran talks to resume after US called off major attack 
Uefa threatens legal action over Infantino’s failed Fifa commercialisation 
Wildfires force mass evacuations across the Pacific Northwest 
